Growth on the Horizon November 2024 May 2025 www.edrsilver.com TSX: EDR | NYSE: EXK TSX: EDR | NYSE: EXK www.edrsilver.com TSE: EDR | NYSE: EXK Cautionary Note This presentation contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within applicable Canadian securities legislation. Such forward-looking statements and information herein include but are not limited to statements regarding Endeavour's acq ...

Financial Data and Key Metrics Changes - Total client assets at the end of March were $171 billion, slightly down from the start of the year, with average AUM approximately 1% lower compared to the fourth quarter [6] - Revenue for the first quarter was $219.6 million, down about 5% from the fourth quarter due to lower average AUM and fewer days in the quarter, but year-over-year revenue was higher [21][22] - Adjusted earnings per diluted share with tax benefit was $1.36, marking the second highest quarterly EPS in company history and a record for any first quarter [9][30] - Adjusted EBITDA was $116 million with a margin of 53%, reflecting a 90 basis point expansion from the first quarter of the previous year [30] Business Line Data and Key Metrics Changes - Gross sales increased by 41% from the last quarter, reaching $9.3 billion, the highest level of quarterly gross sales in three years [6] - The ETF AUM increased to over $13 billion, a 28% increase during the quarter and up 67% year-over-year [8] - The Amundi acquisition resulted in a doubling of fixed income AUM as a percentage of total assets from 14% to 28% [11] Market Data and Key Metrics Changes - The company ended the quarter with $44 billion of AUM sourced from clients outside the U.S., representing 15% of total AUM, compared to less than 5% previously [12][24] - Pioneer Investments generated positive net long-term flows of $1.7 billion in the first quarter, which is not included in the company's numbers due to the transaction closing on April 1 [13][27] Company Strategy and Development Direction - The company is strategically investing in distribution channels, data, technology, marketing, and intermediary partnerships to enhance organic growth [10][19] - Plans for several ETF launches in 2025 are underway, with a focus on expanding the product lineup [9][19] - The company aims to maintain a long-term margin target of 49%, despite short-term integration costs from the Amundi acquisition [45] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the underlying activity around flows, viewing the two large redemptions as one-time events that should not distort organic growth progress [7] - The company is well-positioned for organic growth with a larger sales force and enhanced resources dedicated to distribution efforts [19][66] - Management anticipates a potential acquisition announcement in 2025, leveraging the improved balance sheet and cash position [58] Other Important Information - The company returned $39 million to shareholders during the first quarter and increased the quarterly dividend to $0.49 per share [22] - The net leverage ratio remained steady at 1.7 times, with cash on hand increasing to $176 million [22][31] Q&A Session Summary Question: Can you elaborate on the rollout of new products outside the U.S.? - Management indicated that they are working with Amundi to identify successful products for international markets, with launches expected in the latter half of 2025 [35][38] Question: How will margins evolve in the near term? - Management confirmed that while margins are currently at 53%, they expect a slight decline during integration efforts, but remain bullish on achieving long-term targets of 49% [42][45] Question: What is the state of the acquisition pipeline? - Management stated that the company is in a strong position to execute sizable transactions and is leaning towards larger scaled opportunities [56][58] Question: How are fixed income and solutions performing in volatile markets? - Management noted that the fixed income platform has expanded and performed well, with positive net flows observed in the first quarter [64][66] Question: Have there been any dissynergies from the Amundi acquisition? - Management reported no dissynergies from the Amundi acquisition, highlighting positive net flows from Pioneer Investments [72][74] Question: What investments are being made to enhance organic growth? - Management detailed significant investments in sales, marketing, and data technology to support organic growth, with success measured by growth in business [84][87] Question: How important are alternative investment products for future acquisitions? - Management acknowledged the importance of alternative investments and is evaluating various strategies to incorporate them into the platform [90][92] Question: What is the rationale behind the change in dividend policy? - Management explained that the change allows for more opportunistic increases while prioritizing capital for acquisitions and growth [96][98]

Financial Data and Key Metrics Changes - Total client assets at the end of March were $171 billion, slightly down from the start of the year, with average AUM approximately 1% lower compared to the fourth quarter [4] - Revenue for the first quarter was $219.6 million, down about 5% from the fourth quarter due to lower average AUM and fewer days in the quarter [18] - Adjusted earnings per diluted share with tax benefit was $1.36, marking the second highest quarterly EPS in company history [6][18] - Adjusted EBITDA was $116 million with an EBITDA margin of 53%, reflecting a 90 basis point expansion from the first quarter of the previous year [28] Business Line Data and Key Metrics Changes - Gross sales increased by 41% from the last quarter, reaching $9.3 billion, the highest level of quarterly gross sales in three years [4] - The ETF AUM increased to over $13 billion, a 28% increase during the quarter and up 67% year-over-year [5] - The Amundi U.S. business generated positive net long-term flows of $1.7 billion in the first quarter, which is not included in the current numbers due to the transaction closing on April 1 [11] Market Data and Key Metrics Changes - The proportion of retail assets under management rose, with $44 billion sourced from clients outside the U.S., representing 15% of total AUM compared to less than 5% previously [10] - The investment performance remained strong, with 67% of mutual fund and ETF assets earning four or five-star ratings from Morningstar [17] Company Strategy and Development Direction - The company is strategically investing in distribution channels, data, technology, marketing, and intermediary partnerships to enhance organic growth [7][8] - Plans for several ETF launches in 2025 are underway, with a focus on expanding the product lineup [6][10] - The company aims to maintain a long-term margin target of 49%, despite short-term fluctuations due to integration efforts [44] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the underlying activity around flows, viewing the recent large redemptions as one-time events that should not distort ongoing growth [5] - The company is encouraged by discussions regarding ongoing diligence activities and sees potential for additional strategic growth opportunities [8][56] Other Important Information - The company increased its quarterly dividend to $0.49 per share, payable on June 25, and anticipates moving back to an annual increase cycle [19][95] - The leverage ratio improved significantly following the Amundi transaction, enhancing financial flexibility [8][29] Q&A Session Summary Question: Can you elaborate on the rollout of new products outside the U.S.? - The company is working with Amundi to identify products for international markets, with launches expected in the latter half of 2025 [35][39] Question: How will margins evolve in the near term? - Margins may see a slight decline during integration efforts, but the long-term target remains at 49% [44][45] Question: What is the current state of the acquisition pipeline? - The company is in a strong position to execute sizable transactions and is leaning towards larger scaled opportunities [56][57] Question: Have there been any dissynergies from the Amundi acquisition? - No dissynergies have been observed; the combined business has resonated well in the market [72] Question: What investments are being made to enhance organic growth? - Significant investments in sales, marketing, and data technology are being made to support organic growth [84][85] Question: How important are alternative investment products for future acquisitions? - Alternatives are important, and the company is evaluating various ways to incorporate them into its offerings [88][89]

INVESTOR PRESENTATION May 2025 Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. Such risks and uncertainties include, but are not limited to the following; our business, operations, customers, suppliers nd employees; general economic conditions in the areas of the United States in which the Company's customers are located; changes in the market where uniforms are worn, where ...

FY2025 Second Quarter Earnings Three Months Ended 3.31.25 May 8, 2025 CONFIDENTIAL & PROPRIETARY © Copyright 2025 DLH Holdings Corp. All Rights Reserved. 1 President and Chief Executive Officer Kathryn JohnBull Chief Financial Officer 2 CONFIDENTIAL & PROPRIETARY © Copyright 2025 DLH Holdings Corp. All Rights Reserved. Forward-Looking Statements Call Participants Zach Parker "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking sta ...

Financial Data and Key Metrics Changes - The company reported adjusted operating earnings per share of $2.00 in Q1 2025, reflecting a 13% increase year-over-year [11] - Generated approximately $200 million in cash during the quarter, exceeding the 90% target [12] - GAAP net income was below cash generation due to non-cash items [12] Business Line Data and Key Metrics Changes - In Wealth Solutions, adjusted operating earnings were $207 million, an 11% year-over-year growth, driven by higher fee-based revenues and the acquisition of OneAmerica, which added $60 billion in assets [13] - Investment Management generated $41 million in adjusted operating earnings, with net inflows of $7.7 billion, representing 2.5% organic growth [15] - Health Solutions reported adjusted operating earnings of $46 million, with improved margins and a focus on stabilizing stop-loss experience [17] Market Data and Key Metrics Changes - Wealth Solutions achieved defined contributions organic net flows of approximately $30 billion, with strong performance in healthcare and government markets [6] - Investment Management's net cash flows were broad-based across institutional and retail markets, with significant demand for fixed income and private assets [7][15] - The company noted a strong pipeline supporting long-term organic growth targets of over 2% [8] Company Strategy and Development Direction - The company emphasizes a capital-light business model that generates diverse revenue streams and consistent free cash flow [5] - Focus on innovative workplace solutions and top-notch asset management to create long-term value for stakeholders [5] - Plans to enhance retail wealth management capabilities through modest investments and hiring additional advisors [53][56] Management's Comments on Operating Environment and Future Outlook - Management acknowledged mixed economic signals and elevated market volatility, leading to a cautious approach [8] - The results underscore the strength of the business model, focusing on commercial momentum, cash generation, and maintaining a healthy balance sheet [9] - The company remains optimistic about its ability to navigate the complex environment and drive shareholder value [20] Other Important Information - The company ended the quarter with excess capital of approximately $150 million and a risk-based capital (RBC) ratio of 385% [18] - Approximately $400 million of debt was repaid in February, bringing the leverage ratio within target range [19] Q&A Session Summary Question: Insights on wealth earnings and margin guidance - Management noted that spread-based assets were higher than expected, but they anticipate moderation moving forward [26] Question: Details on voluntary reserves and loss ratio expectations - Reserves were increased due to economic uncertainty, with expectations for a high 40s loss ratio [32] Question: Clarification on stop-loss estimated loss ratio - The estimated loss ratio of 87% for the 2025 cohort is based on improved pricing and risk selection practices [41] Question: Update on voluntary business growth - The company experienced slower top-line growth due to large wins in the previous year not repeating, but the pipeline remains strong [50][52] Question: Free cash flow and earnings outlook - Management indicated that while they are not providing specific guidance, the previous estimate of $8 per share remains a reasonable starting point [59] Question: Impact of severance on expenses - Severance costs were part of ongoing expense management, with no significant future severance expected [105] Question: Investment management net inflows - Net inflows were broad-based across various channels and products, with no outsized mandates driving the results [80]

Core Insights - Techne (TECH) reported revenue of $316.18 million for the quarter ended March 2025, reflecting a year-over-year increase of 4.2% and surpassing the Zacks Consensus Estimate by 0.30% [1] - The company's EPS was $0.56, up from $0.48 in the same quarter last year, resulting in an EPS surprise of 9.80% compared to the consensus estimate of $0.51 [1] Financial Performance - Organic Growth was reported at 6%, exceeding the average estimate of 5.2% from three analysts [4] - Organic Growth in Diagnostics and Genomics was 2%, below the two-analyst average estimate of 6.2% [4] - Organic Growth in Protein Sciences was 7%, significantly higher than the average estimate of 2.8% from two analysts [4] - Net Sales from intersegment revenue was -$0.74 million, worse than the average estimate of -$0.55 million, representing a year-over-year decline of 3.7% [4] - Net Sales in Protein Sciences reached $227.69 million, surpassing the average estimate of $224.75 million, with a year-over-year increase of 6.1% [4] - Net Sales in Diagnostics and Genomics were $89.23 million, slightly below the average estimate of $92.50 million, showing a year-over-year growth of 2% [4] Market Performance - Techne's shares have returned -2.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 10.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

IAMGOLD (IAG) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Speaker0 Thank you for standing by. This is the conference operator. Welcome to the IAMGOLD First Quarter twenty twenty five Operating and Financial Results Conference Call and Webcast. As a reminder today, all participants are in listen only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. At this time, I would like to turn the conference over to Graham Jennings, VP, Investor Relati ...

Financial Data and Key Metrics Changes - The company reported organic sales growth of 2% in Q1 2025, with adjusted EBITDA increasing by 4% excluding foreign exchange impacts [7][8] - Adjusted EBITDA margins expanded by 20 basis points to 17.5%, despite strong comparisons from the previous year [8] - Adjusted EPS was $0.76, representing a 4% growth when excluding unfavorable foreign exchange impacts [8][15] Business Line Data and Key Metrics Changes - The Color, Additives, and Ink segment saw organic sales growth of 3% and adjusted EBITDA growth of 7%, driven by resilient demand in personal care and food and beverage applications [15][16] - The Specialty Engineered Materials segment's organic sales were flat year-over-year, with adjusted EBITDA declining by 4% due to lower sales in transportation and defense markets [16][17] - The healthcare segment experienced double-digit growth, particularly in medical devices and medical supplies [16] Market Data and Key Metrics Changes - Organic sales in the U.S. and Canada declined by 3%, primarily due to weak demand in consumer and transportation end markets [9] - EMEA region grew by 2%, marking the fourth consecutive quarter of organic growth [9] - Asia reported a 9% increase in organic sales, with growth across most end markets, including transportation [10] - Latin America outpaced market growth with a 17% increase in organic sales, continuing a trend of double-digit growth [10] Company Strategy and Development Direction - The company is focused on cost control and productivity, expecting approximately $30 million in savings from initiatives in 2025 [12] - There is a strategic emphasis on maximizing cash flow and reducing debt, with plans to pay down $100 million to $200 million in debt this year [13][23] - The company aims to prioritize investments in growth vectors, particularly in healthcare and defense, which are expected to outperform the broader market [14][20] Management's Comments on Operating Environment and Future Outlook - Management noted that evolving trade policies have led to uncertainty impacting demand in select markets, particularly in the U.S. [8][20] - The company expects second quarter adjusted EPS of $0.79, representing a 4% growth over the prior year quarter [20] - For the full year, the company models different scenarios, with the low end reflecting flat demand and the high end assuming mid-single-digit growth [22] Other Important Information - The company expects minimal direct impact from tariffs, as most raw materials are sourced and products manufactured locally [19] - The company anticipates 1% to 2% inflation in raw material costs for the full year, with specific trends noted in various materials [84] Q&A Session Summary Question: Defense business outlook after a 5% decline in Q1 - Management expects double-digit growth in the defense business for the first half of the year and high single-digit growth for the full year [27] Question: Transportation market outlook and order books - Transportation is expected to see low negative mid-single-digit growth in the first half, aligning with build rate drops in Europe and the U.S. [28][30] Question: Consumer market weakness in Q1 - The consumer market showed double-digit declines in the U.S. and Canada, with expectations for continued weakness in Q2 [33][34] Question: Share gains in EMEA - Strong performance in healthcare, consumer, and defense markets contributed to share gains in EMEA [35] Question: Packaging segment performance - The packaging segment is driven by strong demand in personal care and beverages, with double-digit growth in personal care applications [39][40] Question: Raw material trends and inflation - The company expects 1% to 2% inflation in raw material costs for the full year, with specific materials trending up or down [84][85]

Financial Data and Key Metrics Changes - The company reported organic sales growth of 2% in the quarter, with adjusted EBITDA growing by 4% excluding foreign exchange impacts [6][14] - Adjusted EBITDA margins expanded by 20 basis points to 17.5%, despite strong comparisons from the previous year [7] - Adjusted EPS was $0.76, representing a 4% growth when excluding unfavorable foreign exchange impacts [7][14] Business Line Data and Key Metrics Changes - The Color, Additives, and Ink segment saw organic sales growth of 3% and adjusted EBITDA growth of 7% [14] - The Specialty Engineered Materials segment's organic sales were flat year-over-year, with adjusted EBITDA declining by 4% [15] - The healthcare segment experienced double-digit growth, driven by demand in medical devices and supplies [15][16] Market Data and Key Metrics Changes - Organic sales in the U.S. and Canada declined by 3%, primarily due to weak demand in consumer and transportation markets [8] - EMEA region grew by 2%, marking the fourth consecutive quarter of organic growth [8] - Asia's organic sales increased by 9%, with growth across most end markets, particularly transportation [9] - Latin America outpaced market growth with a 17% increase in organic sales, marking the fourth consecutive quarter of double-digit growth [9] Company Strategy and Development Direction - The company is focused on cost control and productivity, expecting approximately $30 million in savings from initiatives in 2025 [11] - There is a strategic emphasis on maximizing cash flow and reducing debt by $100 million to $200 million this year [12][22] - The company aims to prioritize investments in growth vectors, particularly in healthcare and defense, which are expected to outperform the broader market [13][20] Management's Comments on Operating Environment and Future Outlook - Management noted that evolving trade policies have led to uncertainty impacting demand in select markets, particularly in the U.S. [7][19] - For Q2, the company expects adjusted EPS of $0.79, representing a 4% growth over the prior year [20] - The full-year guidance for adjusted EBITDA remains unchanged at $540 million to $570 million, with adjusted EPS guidance of $2.70 to $2.94 [22] Other Important Information - The company expects minimal direct impact from tariffs, as most raw materials are sourced and manufactured locally [12][18] - There is a focus on innovation and reformulation to mitigate tariff impacts and enhance customer offerings [53][54] Q&A Session Summary Question: Defense business expectations for the rest of the year - Management expects double-digit growth in the first half and high single-digit growth for the full year in the defense sector, despite a 5% decline in Q1 [26][27] Question: Transportation market outlook - Transportation is expected to see low negative mid-single-digit growth in the first half, aligning with build rate drops, but a potential recovery in the second half is anticipated [28][29] Question: Consumer market weakness - The consumer market showed double-digit declines in the U.S. and Canada, with expectations for continued weakness in Q2 [32][34] Question: Share gains in EMEA - Strong performance in healthcare, consumer, and defense markets contributed to share gains in EMEA, with notable wins in energy infrastructure [35] Question: Packaging segment performance - The packaging segment is driven by strong demand in personal care and beverages, with double-digit growth in personal care applications [39][40] Question: Raw material trends and inflation - The company expects 1% to 2% inflation for the full year, with specific raw materials showing varied trends [84][85] Question: Cash flow and incentive payouts - The cash flow statement reflects a $53 million use of cash related to incentive accruals, primarily from Q1 payouts [80][81]